There are multiple lines of evidence suggesting that soluble epoxide hydrolase (sEH) deficiency or inhibition can attenuate parkinsonism in MPTP-treated mice (Qin et al., 2015; Pallas et al., 2020). This evidence concerns the gene EPHX2 and Parkinsonism.